Johnston Erwin has persuaded some old friends to up their bet on TRexBio. Twenty months after taking over as CEO of the biotech, the Eli Lilly veteran has landed a deal with his former employer that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback